![Simon Bennett](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Simon Bennett
Corporate Officer/Principal bei
THALIA THERAPEUTICS PLC
Profil
Simon Bennett is currently Managing Director at Dr. Bennett Associates Ltd since 2010 and Head of Business Development at Thalia Therapeutics Plc starting in 2025.
Former roles include Director of Business Development at Oxagen Ltd. from 1997 to 2003, Director of Business Development at Illumina Cambridge Ltd. from 2003 to 2005, Director of Business Development at MedPharm Ltd. from 2005 to 2006, Vice President of Business Development at Glide Pharmaceutical Technologies Ltd. from 2006 to 2010, and Chief Business Officer at Avacta Group Plc.
Aktive Positionen von Simon Bennett
| Unternehmen | Position | Beginn |
|---|---|---|
| THALIA THERAPEUTICS PLC | Corporate Officer/Principal | 27.05.2025 |
Simon Bennett Associates Ltd
 Simon Bennett Associates Ltd Miscellaneous Commercial ServicesCommercial Services Provides management consultancy services | Vorstandsvorsitzender | 01.07.2010 |
Ehemalige bekannte Positionen von Simon Bennett
| Unternehmen | Position | Ende |
|---|---|---|
Glide Pharmaceutical Technologies Ltd.
 Glide Pharmaceutical Technologies Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | 01.06.2010 |
MedPharm Ltd.
 MedPharm Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a topical and transdermal contract development & manufacturing organization | Corporate Officer/Principal | 01.01.2006 |
Solexa Ltd.
 Solexa Ltd. BiotechnologyHealth Technology Develops DNA sequencing and array-based life sciences technologies | Corporate Officer/Principal | 01.05.2005 |
Oxagen Ltd.
 Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Corporate Officer/Principal | 01.09.2003 |
| AVACTA GROUP PLC | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
19
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Oxagen Ltd.
Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Develops novel molecule drugs to treat inflammatory and respiratory diseases | Health Technology |
Solexa Ltd.
Solexa Ltd. BiotechnologyHealth Technology Develops DNA sequencing and array-based life sciences technologies | Health Technology |
Avacta Group Plc
 Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
MedPharm Ltd.
MedPharm Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a topical and transdermal contract development & manufacturing organization | Commercial Services |
Glide Pharmaceutical Technologies Ltd.
Glide Pharmaceutical Technologies Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
N4 Pharma Plc
 N4 Pharma Plc BiotechnologyHealth Technology Provides specialist pharmaceutical services that reformulates existing drugs and vaccines to improve their performance | Health Technology |
Simon Bennett Associates Ltd
Simon Bennett Associates Ltd Miscellaneous Commercial ServicesCommercial Services Provides management consultancy services | Commercial Services |
